Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • AUSTRALIA & NEW ZEALAND STEM CELL MARKET FORECAST 2022-2028

AUSTRALIA & NEW ZEALAND STEM CELL MARKET FORECAST 2022-2028

The Australia & New Zealand stem cell market is likely to grow with a CAGR of 10.50% during the estimated period, capturing a revenue share of $481.29 million by 2028. The base year considered for the market study is 2021, and the forecast years are from 2022 to 2028.

AUSTRALIA & NEW ZEALAND STEM CELL MARKET FORECAST 2022-2028

Australia & New Zealand Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) Market by Product (Adult Stem Cell, Human Embryonic Stem Cell, Pluripotent, Mouse/Rat Neural) Market by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture)

Request free sample

The Australia & New Zealand stem cell market is likely to grow with a CAGR of 10.50% during the estimated period, capturing a revenue share of $481.29 million by 2028. The base year considered for the market study is 2021, and the forecast years are from 2022 to 2028.

Australia & New Zealand Stem Cell Market

To know more about this report, request a free sample copy

The market growth of the country is credited to the increasing healthcare expenditure as well as favorable government support.

Cutaneous tissue regeneration and the paracrine promotion of wound healing are two core areas where stem cells hold significant promise. Moreover, in-depth research is also being conducted on numerous cell types, such as resident tissue stem cells, embryonic stem cells, mesenchymal stem cells, adipose-derived stem cells, epithelial stem cells, hematopoietic stem cells, and others.

According to the Organisation for Economic Co-operation and Development, Australia spent nearly 8.8% of its gross domestic product (GDP) on healthcare in the year 2018. Besides, the healthcare expenditure pattern is similar to European nations, with around 15% of the outlay accounting for pharmaceuticals, annually. The Australian government also places significant emphasis on the development of technologies as well as procedures that would facilitate improved health outcomes.

On the other hand, the stem cell business in Australia is predominantly recognized by the Australian Stem Cell Centre, which concentrates on regenerative medicine through the use of stem cells. Likewise, the NSW Stem Cell Network is also a well-developed community across the nation that endeavors toward stem cell forms. As a result, these factors are anticipated to play a pivotal role in accelerating the stem cell market in the region during the forecasted years.

The Australia & New Zealand stem cell market is segmented into therapeutic application, product, technology, application, and treatment type. The application segment includes regenerative medicine and drug discovery and development. Stem cells have proven to be significant contributors to regenerative medicine. A key factor propelling the growth of the stem cell market entails the therapeutic potential for diseases such as diabetes, cancer, and cardiovascular ailments. Furthermore, their applications are also proliferating in the avenue of hematological and neurological conditions, in addition to fields like systemic lupus, organ transplants, infertility, and Crohn’s disease.

Conversely, biopharmaceutical firms have been establishing efforts toward deciphering stem cell technologies’ vital applications in the drug development processes. This would help reduce the high attrition rate of late-stage drug candidates, which has been rapidly growing over the last decade. In this regard, stem cell therapy has delivered an innovative beginning for the expansion of methodologies. Owing to this, lead compounds can be identified and introduced to the market as new drugs, thereby envisaging stem cells as a possible reservoir for encountering medical challenges

Some of the major corporations operating in the Australia & New Zealand stem cell market are Corning Inc, GE Healthcare, Merck KGaA (Sigma Aldrich), etc.

Corning Inc, headquartered in the United States, manufactures and commercializes ceramic, specialty gasses, as well as related materials in the Asia-Pacific, Europe, North America, and internationally. The company’s five operating segments include display technology, optical communication, specialty material, environmental technologies, and life science.

Cell culture surfaces coated with the Corning Human Fibronectin (HFN) are utilized for the improvement of cell attachment. Moreover, they are facilitated by the central cell-binding domain of the FN via the RGD (Arg-Gly-Asp) amino acid sequence.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2028
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Therapeutic Application, Product, Technology, Application, Treatment Type
Countries Analyzed Australia & New Zealand
Companies Analyzed

Corning Inc, GE Healthcare, Merck KGaA (Sigma Aldrich), Qiagen, Smith+Nephew PLC, Takara Holdings Inc, Thermo Fisher Scientific Inc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON STEM CELL MARKET
      • KEY MARKET TRENDS
      • PESTLE ANALYSIS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
        • PRICE
        • EFFICACY
        • APPLICATION AND EFFECTIVENESS
        • ACCURACY
      • REGULATORY FRAMEWORK
    4. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES & WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    5. MARKET BY PRODUCT
      • ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM CELL
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    6. MARKET BY TECHNOLOGY
      • CELL ACQUISITION
        • BONE MARROW HARVEST
        • UMBILICAL CORD
        • APHERESIS
      • CELL PRODUCTION
        • THERAPEUTIC CLONING
        • IN VITRO FERTILIZATION (IVF)
        • CELL CULTURE
        • ISOLATION
      • CRYOPRESERVATION
      • EXPANSION & SUB-CULTURE
    7. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    8. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY
    9. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • ACQUISITIONS
        • PARTNERSHIPS
      • COMPANY PROFILES
        • CORNING INC
        • GE HEALTHCARE
        • MERCK KGAA (SIGMA ALDRICH)
        • QIAGEN
        • SMITH+NEPHEW PLC
        • TAKARA HOLDINGS INC
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: AUSTRALIA & NEW ZEALAND – COUNTRY SNAPSHOT

    TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS

    TABLE 3: REGULATORY FRAMEWORK

    TABLE 4: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 6: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 8: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 10: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 11: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 12: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 13: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 14: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 15: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 16: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 17: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 18: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 19: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 20: LIST OF ACQUISITIONS

    TABLE 21: LIST OF PARTNERSHIPS   

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION

    FIGURE 3: PESTLE ANALYSIS

    FIGURE 4: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 5: OPPORTUNITY MATRIX

    FIGURE 6: VENDOR LANDSCAPE

    FIGURE 7: VALUE CHAIN ANALYSIS

    FIGURE 8: KEY BUYING CRITERIA

    FIGURE 9: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021

    FIGURE 10: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2028 (IN $ MILLION)

    FIGURE 11: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2028 (IN $ MILLION)

    FIGURE 12: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2028 (IN $ MILLION)

    FIGURE 13: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2028 (IN $ MILLION)

    FIGURE 14: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2028 (IN $ MILLION)

    FIGURE 15: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DIABETES, 2022-2028 (IN $ MILLION)

    FIGURE 16: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2028 (IN $ MILLION)

    FIGURE 17: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 18: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 19: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021

    FIGURE 20: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 21: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 22: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 23: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 24: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)

    FIGURE 25: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2028 (IN $ MILLION)

    FIGURE 26: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PLURIPOTENT, 2022-2028 (IN $ MILLION)

    FIGURE 27: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2028 (IN $ MILLION)

    FIGURE 28: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

    FIGURE 29: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, 2022-2028 (IN $ MILLION)

    FIGURE 30: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021

    FIGURE 31: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2028 (IN $ MILLION)

    FIGURE 32: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY UMBILICAL CORD, 2022-2028 (IN $ MILLION)

    FIGURE 33: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APHERESIS, 2022-2028 (IN $ MILLION)

    FIGURE 34: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, 2022-2028 (IN $ MILLION)

    FIGURE 35: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021

    FIGURE 36: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2028 (IN $ MILLION)

    FIGURE 37: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2028 (IN $ MILLION)

    FIGURE 38: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL CULTURE, 2022-2028 (IN $ MILLION)

    FIGURE 39: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ISOLATION, 2022-2028 (IN $ MILLION)

    FIGURE 40: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2028 (IN $ MILLION)

    FIGURE 41: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2028 (IN $ MILLION)

    FIGURE 42: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 43: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2028 (IN $ MILLION)

    FIGURE 44: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2028 (IN $ MILLION)

    FIGURE 45: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021

    FIGURE 46: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)

    FIGURE 47: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)

    FIGURE 48: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)       

    1. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES & WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    2. MARKET BY PRODUCT
      • ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM CELL
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    3. MARKET BY TECHNOLOGY
      • CELL ACQUISITION
        • BONE MARROW HARVEST
        • UMBILICAL CORD
        • APHERESIS
      • CELL PRODUCTION
        • THERAPEUTIC CLONING
        • IN VITRO FERTILIZATION (IVF)
        • CELL CULTURE
        • ISOLATION
      • CRYOPRESERVATION
      • EXPANSION & SUB-CULTURE
    4. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    5. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now